Group
|
TIVAD-related infections
|
Catheter-related thrombotic complications
|
Total major mechanical complications
|
---|
N
|
OR (95 % CI)
|
I2(%)
|
P
heterogeneity
|
N
|
OR (95 % CI)
|
I2(%)
|
P
heterogeneity
|
N
|
OR (95 % CI)
|
I2(%)
|
P
heterogeneity
|
---|
Overall
|
11
|
0.71 (0.48–1.04)
|
0.0
|
0.963
|
11
|
0.76 (0.38–1.51)
|
30.2
|
0.159
|
11
|
0.38 (0.24–0.61)
|
31.6
|
0.147
|
Use of antibiotic prophylaxis
|
Yes
|
3
|
0.69 (0.27–1.76)
|
0.0
|
0.611
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
No
|
2
|
0.69 (0.39–1.24)
|
0.0
|
0.618
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Use of ultrasound guidance
|
Yes
|
1
|
0.40 (0.02–6.41)
|
NA
|
NA
|
1
|
1.00 (0.19–5.23)
|
NA
|
NA
|
1
|
0.39 (0.08–1.98)
|
NA
|
NA
|
No
|
6
|
0.76 (0.47–1.24)
|
0.0
|
0.798
|
5
|
0.44 (0.18–1.05)
|
0.0
|
0.860
|
6
|
0.38 (0.18–0.79)
|
46.3
|
0.098
|
Age Group
|
< 18 yr
|
1
|
0.50 (0.14–1.80)
|
NA
|
NA
|
1
|
0.41 (0.02–10.40)
|
NA
|
NA
|
1
|
0.27 (0.10–0.76)
|
NA
|
NA
|
≥ 18 yr
|
3
|
0.44 (0.16–1.22)
|
0.0
|
0.972
|
4
|
1.13 (0.28–4.61)
|
56.8
|
0.073
|
3
|
0.61 (0.15–2.56)
|
56.5
|
0.100
|
- Abbreviations: N Number of studies, NA not applicable, yr years old
- aAll these analyses were performed with random-effects model